National University Hospital

NUH LAUNCHES NEW DIGESTIVE CENTRE TO PUSH NEW FRONTIERS IN EARLY CANCER DETECTION AND CARE EXCELLENCE

Retrieved on: 
Tuesday, April 16, 2024
Radiation, Cade, Cancer, CAQ, Mouth, Pancreas, Tissue, AI, Colorectal cancer, Prognosis, Annual report, Stomach, Surgeon, Digestate, Artificial intelligence, Stomach cancer, Consultant, Hepatology, Radiology, National University Hospital, Computer, Incidence, Patient, Endoscopy, Diagnosis, Biomarker, Associate, Liver cancer, Division, Head, NUH, Medical imaging

SINGAPORE, April 16, 2024 /PRNewswire/ -- The National University Hospital (NUH) is embarking on a major initiative to establish the National University Centre for Digestive Health, slated for completion in the first half of 2025. With a vision to be the region's leading academic centre for digestive health, the Centre will pioneer research, innovations and clinical practices with an amplified focus to elevate the standards of early disease detection, precise diagnosis, treatment and prevention of digestive illnesses.

Key Points: 
  • Early gastrointestinal lesions, which are abnormal changes involving the tissues in the stomach area, may be indicative of cancer.
  • As such, early detection and diagnosis are crucial for better prognosis and lay a strong foundation for successful treatment and recovery.
  • The team is also developing novel biomarkers to improve the precision of early colorectal cancer detection, as well as new pancreas and liver cancer assays.
  • As we continue to expand our infrastructure and embrace technological advances, the Centre is poised to redefine digestive health for the future."

KFSH&RC Welcomes Dr. Björn Zoéga as New Deputy CEO

Retrieved on: 
Tuesday, April 2, 2024
Karolinska University Hospital, Health, Education, Research, RC, Karolinska Institute, Landspítali, KFSH, National University Hospital

RIYADH, Saudi Arabia, April 02, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the appointment of Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective 01 April 2024. This strategic move is set to accelerate KFSH&RC's aspiration of becoming a leading healthcare institution on the global stage, leveraging Dr. Zoéga's notable career and proven track record of leadership in top-tier medical institutions.

Key Points: 
  • RIYADH, Saudi Arabia, April 02, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the appointment of Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective 01 April 2024.
  • His administration at Karolinska was marked by innovative strategies and excellence in healthcare delivery—all which he is posed to enrich within KFSH&RC.
  • Dr. Zoégabrings decades of healthcare management and clinical expertise to KFSH&RC, having spearheaded operations as CEO of the National University Hospital of Iceland and the Stockholm Spine Center.
  • As Deputy CEO, Dr. Zoéga will serve as chief lead of KFSH&RC’s healthcare delivery and research and innovation groups, following on the hospital’s commitment to integrating global best practices in healthcare and pursuing cutting-edge medical research and technology.

OFFICIAL LAUNCH OF THE NATIONAL UNIVERSITY SPINE INSTITUTE (NUSI): LEADING SPINE CARE INTO THE FUTURE

Retrieved on: 
Saturday, March 30, 2024
NUH, Research, Spinal stenosis, Conference, Health, MRI, National University Health System, Column (periodical), Radiology, Associate, Magnetic resonance imaging, Consultant, Education, Orthopedic surgery, Patient, Ageing, Degenerative disc disease, Knowledge, Artificial intelligence, Human, Deep learning, Deformity, National University Hospital, Scoliosis, Osteoporosis, Spine, Pain management, NUHS, Rehabilitation, Person, Nursing

SINGAPORE, March 30, 2024 /PRNewswire/ -- The National University Spine Institute (NUSI) is a new dedicated specialist spine institute under the National University Health System (NUHS) that provides multidisciplinary care for patients with spinal diseases and deformities.

Key Points: 
  • SINGAPORE, March 30, 2024 /PRNewswire/ -- The National University Spine Institute (NUSI) is a new dedicated specialist spine institute under the National University Health System (NUHS) that provides multidisciplinary care for patients with spinal diseases and deformities.
  • Under the leadership of Associate Professor Gabriel Liu, NUSI aims to set new standards in spine care through a patient-centric approach.
  • A/Prof Liu said: "NUSI differentiates itself by providing dedicated sub-specialties within the spine practice, standardising work processes and providing value-driven patient care across the cluster to address spinal problems.
  • NUSI is dedicated to developing community care programmes for patients, with cases expected to rise in the coming years partly due to an ageing population."

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Retrieved on: 
Monday, March 4, 2024
IIT, Regenerative medicine, Research, Microsoft Exchange Server, News, Ageing, Cancer, GMP, Cartilage, Cell, National University Hospital, SingHealth, SKH, B cell, Safety, UC, Transplant, Knee, Patient, Clinical trial, Osteoarthritis, MSC, Umbilical cord, RCA, Pharmaceutical industry

Osteoarthritis of the knee is a debilitating disease affecting Singapore’s aging population and the clinical trial will pioneer stem cell use for regenerative medicine in Singapore.

Key Points: 
  • Osteoarthritis of the knee is a debilitating disease affecting Singapore’s aging population and the clinical trial will pioneer stem cell use for regenerative medicine in Singapore.
  • UC-MSCs are a type of adult stem cells that can be isolated from the umbilical cord tissue after childbirth.
  • UC-MSCs are considered multipotent and are able to differentiate into different cell types, including bone, cartilage, fat, and muscle cells.
  • "Our collaboration with CytoMed marks a significant step in advancing research on allogeneic in-vivo UC-MSC for cartilage repair, including osteoarthritis of the knee.

AI Medical Service Inc. Completes First Regulatory Review and Device Registration of Gastric AI-based Endoscopic Diagnosis Support System from Singapore’s HSA

Retrieved on: 
Tuesday, February 20, 2024
University, Start-Up, Education, Technology, Professional Services, Health, Oncology, Medical Devices, Software, Artificial Intelligence, Hospitals, Incidence, Stomach cancer, Multimedia, Physician, NUH, Nature, AIM, Communication, National University Hospital, Stomach, HSA, Extrapyramidal system, Disease, Mortality, Cancer, Medical device

AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce the first instance of Singaporean regulatory review and device registration for an AI-based endoscopic diagnostic support device that operates within the stomach (brand name: Endoscopic image diagnosis support software - gastroAI-model G).

Key Points: 
  • AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce the first instance of Singaporean regulatory review and device registration for an AI-based endoscopic diagnostic support device that operates within the stomach (brand name: Endoscopic image diagnosis support software - gastroAI-model G).
  • The regulatory review and device registration was conducted by Singapore’s Health Sciences Authority (hereinafter HSA) on February 19, 2024.
  • The endoscopic AI (hereinafter gastric cancer differentiation AI) differentiates gastric lesions and judges them as either neoplastic or non-neoplastic in nature.
  • In countries with a high incidence of gastric cancer like Japan and South Korea, endoscopic gastric cancer screening is routinely performed nationwide.

Wonder Tech's Breakthrough in Language Agnostic Voice AI to Bring Scalable Depression Screening to One Billion People Globally

Retrieved on: 
Tuesday, November 28, 2023
Ministry, DSM-IV codes, Mental, Schizophrenia, Depression, B2B, GDP, Risk, Cardiovascular disease, Insurance, Patient, National University Hospital, Tech, NUH, Anxiety, Bipolar disorder, Diagnosis, Cancer, Speech, SingHealth, Software as a service, PTE, Mental health, Biomarker, AI, DSM-V, Approximation error, Human, Ministry of Health, Medical device, Nursing, Health

LTD ("Wonder Tech" or "the Company"), a leading AI-driven mental health solutions company based in Singapore, has reached a breakthrough in its acoustics-based AI for depression screening.

Key Points: 
  • LTD ("Wonder Tech" or "the Company"), a leading AI-driven mental health solutions company based in Singapore, has reached a breakthrough in its acoustics-based AI for depression screening.
  • The AI model, which identifies depression through detecting nuanced vocal changes, has reached an industry-leading 83% in detection accuracy, surpassing the 80% threshold required for clinical depression detection.
  • With this milestone, Wonder Tech has proven its potential to enable a scalable and adaptable diagnostic tool to help the one billion people affected by mental health disorders worldwide.
  • Wonder Tech also received financial and clinical support from Singapore's Ministry of Health to scale out the solution with leading mental health institutes.

NATIONAL UNIVERSITY HOSPITAL LAUNCHES GLOBAL FELLOWS ALLIANCE TO FOSTER INTERNATIONAL HEALTHCARE COLLABORATION

Retrieved on: 
Thursday, October 19, 2023
Knowledge, NUH, Health care, National University Hospital, Neurology, Public key certificate, Research, Federation of State Medical Boards, Obstetrics and gynaecology, Obstetrics, Vascular surgery, Organ transplantation, Gynaecology, Nursing, Creative industries

SINGAPORE, Oct. 19, 2023 /PRNewswire/ -- In line with its mission of being Singapore's leading university hospital, the National University Hospital (NUH) is launching its highly anticipated Global Fellows Alliance. This is a pioneering initiative that aims to open doors for clinicians to engage with one another, collaborate on innovative healthcare solutions, and contribute to the advancement of medical knowledge in the region and beyond.

Key Points: 
  • SINGAPORE, Oct. 19, 2023 /PRNewswire/ -- In line with its mission of being Singapore's leading university hospital, the National University Hospital (NUH) is launching its highly anticipated Global Fellows Alliance.
  • On 19 October, more than 50 of these fellows are gathering back in Singapore for the official launch of the Global Fellows Alliance.
  • The Global Fellows Alliance will offer a unique blend of educational activities, professional development and networking opportunities.
  • Professor Quek Swee Chye, Chairman of the Medical Board at NUH, said: "Healthcare knows no borders and the Global Fellows Alliance is a testament to our shared commitment to strengthening healthcare excellence on a global scale.

SINGAPORE AND JAPAN CLINICIAN-SCIENTISTS COLLABORATE ON GROUNDBREAKING TELESURGERY TRIAL SPANNING OVER 5,000KM

Retrieved on: 
Wednesday, October 11, 2023
Yong Loo Lin School of Medicine, Consultant, Gastrectomy, Multimedia, Knowledge, MOU, Partnership, National university, NUH, Fujita Health University, Risk, FHU, Travel, National University of Singapore, Cancer, Pandemic, National University Hospital, Memorandum, Assistant, University, Surgeon, Infection, Emergency, Patient, Health insurance, Dentistry, Nursing, Medicine

SINGAPORE, Oct. 11, 2023 /PRNewswire/ -- Singapore's National University Hospital (NUH) and the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) are collaborating with Fujita Health University (FHU) in its first robotic telesurgery trial between Singapore and Japan, from 9 to 11 October 2023.

Key Points: 
  • Leveraging Japan's first surgical robot, clinician-scientists from NUH and NUS Medicine will remotely perform a gastrectomy (stomach surgery performed for cancer) from a surgeon cockpit in Singapore.
  • This collaboration follows the Memorandum of Understanding (MOU) signed in August 2023 between NUS Medicine and FHU, one of Japan's leading universities with a strong research focus in robotic surgery and telesurgery.
  • In Japan, the surgical team is led by Professor Ichiro Uyama and Professor Koichi Suda from Fujita Health University.
  • During public health crises, such as a global pandemic, remote telesurgery helps minimise the risk of disease transmission between patients, healthcare workers, and surgical teams.

Nature-inspired pressure sensing technology aims to transform healthcare and surgical robots

Retrieved on: 
Friday, August 18, 2023
Tissue, Medical school, Pressure, Science, Surgeon, Headache, Atmosphere, Engineering, Intuition, National University of Singapore, Consultant, National university, National University Hospital, Perception, Prognosis, Skull, Multimedia, Brain damage, General surgery, Yale-NUS College, Associate, Movement, Lotus, Patent, Nature Materials, Ng Teng Fong General Hospital, Hospital, System, ICP, NUS, Intracranial pressure, Medical imaging, Instrumentation, 3D printing, Medicine

SINGAPORE, Aug. 18, 2023 /PRNewswire/ -- Researchers at the National University of Singapore (NUS) have developed a novel aero-elastic pressure sensor, called 'eAir'. This technology can be applied to minimally-invasive surgeries and implantable sensors by directly addressing the challenges associated with existing pressure sensors.

Key Points: 
  • This technology can be applied to minimally-invasive surgeries and implantable sensors by directly addressing the challenges associated with existing pressure sensors.
  • It can potentially transform laparoscopic surgeries by enabling tactile feedback for surgeons, allowing more precise manipulation of patient tissues.
  • Mimicking this effect, the team has engineered a pressure sensor designed to significantly improve the sensing performance.
  • At the same time, they have filed a patent for the eAir sensor technology in Singapore, and aims to translate the technology for real-world applications.

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Retrieved on: 
Tuesday, August 1, 2023
GMP, China National Intellectual Property Administration, Patent, Antigen, CNIPA, Partnership, IPSC, NKT, STAR, National University Hospital, Clinical trial, Cell, Immunotherapy, CN, NUH, Agency for Science, Technology and Research, Hematological Cancer Research Investment and Education Act, Biological patents in the United States, Risk, A*STAR, Cytomics, Blood, Agency, Cancer, Same, Outline of health sciences, Health Sciences Authority, T, HSA, NKG2D, Pharmaceutical industry, Vaccine, Science, Research

SINGAPORE, Aug. 1, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based immunotherapies for the treatment of various cancers, announced that the chimeric antigen receptor gamma delta T cell (CAR-γδ T cell) technology, which is exclusively licensed from the Agency for Science, Technology and Research (A*STAR), has been granted a patent by the China National Intellectual Property Administration (CNIPA).

Key Points: 
  • The Company holds an exclusive, worldwide license, for use in immunotherapy, including stem cell therapy, until the expiration of the patent covering technology.
  • CytoMed's CAR-γδ T cell technology has been developed as an investigational cancer therapy to target NKG2D ligands, a type of stress-induced cancer antigens.
  • The Company's other licensed technology from A*STAR is an induced pluripotent stem cell (iPSC)-based technology to derive a novel synthetic γδ NKT cells for the treatment of various types of cancers.
  • A patent for this proprietary technology has already been granted in Japan, and this asset is under preclinical development.